• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Open Music Initiative: Seeking To Drive The Beat On Global Standards, Rights Attribution

28/11/2018 by David Branigan, Intellectual Property Watch 1 Comment

NEW YORK – The Open Music Initiative provides a forum for collaboration across academic, tech and music industry stakeholders around the world, and is working to develop the global standards for music rights attribution that could stand for the next 100 years. Establishing such standards will enable fair compensation to rights holders and creators, and establish a basis for ongoing innovation in the music industry, leading to new digital platforms and services, and new music, according to Open Music members.

Filed Under: Features, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Information and Communications Technology/ Broadcasting, Lobbying, North America, Regional Policy

A Look At The Proposed EU IP Exception To Promote Generic, Biosimilar Industry Competitiveness

16/11/2018 by David Branigan, Intellectual Property Watch 1 Comment

The European Commission has proposed an exception to the extended period of patent protection that the European Union provides to original drug manufacturers for certain products, in order to boost the competitiveness of EU generic and biosimilar industries in global markets. The exception will allow EU generic and biosimilar companies to manufacture protected drugs for export during this patent extension period. Stakeholders are so far unhappy with the exception. Meanwhile, studies analyse its potential economic impacts and legal implications, and the Commission remains confident that safeguards it is putting in place will keep the lower-priced medicines from making their way back into the EU.

Filed Under: Features, IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Europe, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

Key Hepatitis C Drug Licensed To Medicines Patent Pool, Access Expanded For LMICs

12/11/2018 by David Branigan, Intellectual Property Watch 2 Comments

A key drug to treat hepatitis C has been licensed to the Medicines Patent Pool, enabling generic production and expanding affordable access to the drug in low and middle-income countries, excluding the very largest. The agreement between the Pool and AbbVie had been over a year in the making, MPP Executive Director Charles Gore told Intellectual Property Watch.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Human Rights, Other International Orgs, Patents/Designs/Trade Secrets, WHO

“Peace Has Broken Out” In Software Development, Heralding Open Source As The Future

07/11/2018 by David Branigan, Intellectual Property Watch Leave a Comment

“Peace has broken out” between big technology companies and the free and open source software (FOSS) community, according to a leading FOSS advocate, leading a tech industry representative to say, “this is the future.”

Filed Under: IP Policies, Language, Subscribers, Themes, Enforcement, English, Patents/Designs/Trade Secrets

Report Finds “Overpatenting”, Overpricing Of Top Diabetes Drug In US

05/11/2018 by David Branigan, Intellectual Property Watch 1 Comment

Non-profit patent researchers studying the most prominent prescription insulin drug to treat diabetes in the United States found it is “overpatented” and “overpriced,” enabling unwarranted price-hikes resulting in rising costs for patients and taxpayers.

Filed Under: IP Policies, Themes, Venues, English, Health & IP, Human Rights, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Regional Policy

UAEM: In ‘Historic” Shift, Universities In Canada Adopt Licensing Promoting Access To Medicines

01/11/2018 by Intellectual Property Watch Leave a Comment

Universities Allied for Essential Medicines (UAEM) announced today that University of Calgary and McGill University are joining University of British Columbia in adopting Global Access Licensing Principles. These principles promote public access to publicly-funded medicines and life-saving health technologies developed in universities, according to a UAEM press release [pdf].

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Finance, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

Group Proposes Regulating Internet Hate Speech Through Decentralisation

01/11/2018 by David Branigan, Intellectual Property Watch Leave a Comment

French advocacy group La Quadrature du Net has declared recent French government plans to regulate internet hate speech insufficient, and is calling for more in-depth reforms. These could include the promotion of alternative social media platforms and a decentralised approach to regulation, according to an organisation press release.

Filed Under: IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Human Rights, Information and Communications Technology/ Broadcasting, Lobbying, Regional Policy, Trademarks/Geographical Indications/Domains

Advocates Call For New US Federal Authority On Artificial Intelligence

31/10/2018 by Intellectual Property Watch Leave a Comment

Public Knowledge, a Washington, DC advocacy group, today released a paper calling for the formation of a new federal government authority to develop expertise and capacity on artificial intelligence (AI), to be able to effectively regulate and govern these technologies in the future.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Copyright Policy, English, Human Rights, Lobbying, New Technologies, North America, Regional Policy

Report: Is China Gaining The Inside Track On Standards For “Internet Of Things” Technology?

31/10/2018 by David Branigan, Intellectual Property Watch Leave a Comment

A new US private sector report asserts that China is gaining the inside track on international standard-setting for “Internet of Things” technology, and offers strategies for the United States to keep competitive in the marketplace by maintaining influence over standard-setting while protecting data security.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Innovation/ R&D, Lobbying, New Technologies, North America, Other International Orgs, Patents/Designs/Trade Secrets, Regional Policy

New Report: Mitigating Patent Linkage To Promote Medicines Access In LMICs

26/10/2018 by David Branigan, Intellectual Property Watch 1 Comment

A new report reviews how patent linkage mechanisms have been implemented in South Korea, Australia, Canada, and the United States, and identifies precedents for how low and middle-income countries (LMICs) can retain and exploit “constructive ambiguities” in trade treaty text to mitigate the impacts of patent linkage mechanisms and promote the timely availability of generic medicines.

Filed Under: IP Policies, Language, Themes, Venues, Bilateral/Regional Negotiations, Development, English, Health & IP, Human Rights, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WTO/TRIPS

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting